tech-scienceKXFDAAPPROVALDATENTLAOpen
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
YesBuy Yes
30¢
30% implied probability
NoBuy No
71¢
71% implied probability
Volume$1.1K
Liquidity—
Open Interest$1.1K
ExpiresJul 1, 2027
Yes Price$0.30
No Price$0.71
ResolvedPending
OutcomePending
Probability Distribution
Yes 30%
71% No
Description
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.
Market Details
ID6451
Platformkalshi
Categorytech-science
SubcategoryKXFDAAPPROVALDATENTLA
StatusOpen
CreatedApr 17, 2026
ExpiresJul 1, 2027
Resolved—